HCPLive’s Post

Discover how different manifestations of plaque psoriasis influence treatment choice, and discuss when it may be appropriate for certain patients to transition to systemics. Watch Now bit.ly/40j11a6

Discover how different manifestations of plaque psoriasis influence treatment choice, and discuss when it may be appropriate for certain patients to transition to systemics. Watch Now bit.ly/40j11a6

Discover how different manifestations of plaque psoriasis influence treatment choice, and discuss when it may be appropriate for certain patients to transition to systemics. Watch Now bit.ly/40j11a6

Discover how different manifestations of plaque psoriasis influence treatment choice, and discuss when it may be appropriate for certain patients to transition to systemics. Watch Now bit.ly/40j11a6

Discover how different manifestations of plaque psoriasis influence treatment choice, and discuss when it may be appropriate for certain patients to transition to systemics. Watch Now bit.ly/40j11a6

Discover how different manifestations of plaque psoriasis influence treatment choice, and discuss when it may be appropriate for certain patients to transition to systemics. Watch Now bit.ly/40j11a6

Discover how different manifestations of plaque psoriasis influence treatment choice, and discuss when it may be appropriate for certain patients to transition to systemics. Watch Now bit.ly/40j11a6

Discover how different manifestations of plaque psoriasis influence treatment choice, and discuss when it may be appropriate for certain patients to transition to systemics. Watch Now bit.ly/40j11a6

Discover how different manifestations of plaque psoriasis influence treatment choice, and discuss when it may be appropriate for certain patients to transition to systemics. Watch Now bit.ly/40j11a6

Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure. Joshua D. Newman, MD et al. JACC VOL. 83, NO. 9, 2024. March 5. To treat HFrEF with AF, it was shown to reduce mortality with ARB, ARNI, MRA, SGLT2i, Rhythm Control and Ablation and for HEmr and HFpEF (AF) with MRA, SGLT2i and Rhythm Control. BBs reduce mortality in HFrEF and HFmrEF (SR) in sinus rhythm. https://lnkd.in/dSaXxRmM